Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 5Neoplasms 3Glioblastoma 3Colorectal Neoplasms 3Skin Neoplasms 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Hot Flashes 2Vulvodynia 1Thromboembolism 1Severe Acute Respiratory Syndrome 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Hemorrhage 1Pleural Effusion, Malignant 1Platinum Resistant Ovarian Cancer 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Neutropenia 1Neoplasm, Residual 1Neoplasm Metastasis 1Myasthenia Gravis 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Water 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Vulvodynia × Sodium Chloride × Clear all
NCT01539317 2017-04-14

Therapy to Prevent Sexual Pain in Breast Cancer Survivors

OHSU Knight Cancer Institute

Phase 3 Completed
50 enrolled 9 charts
Breast

Breast Neoplasms, Dyspareunia, Vulvodynia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡